These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 6220041)

  • 1. Distal colon motility as a predictor of antidepressant response to fenfluramine, imipramine and clomipramine.
    Lechin F; Van der Dijs B; Gómez F; Arocha L; Acosta E; Lechin E
    J Affect Disord; 1983 Feb; 5(1):27-35. PubMed ID: 6220041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distal colon motility and clinical parameters in depression.
    Lechin F; Van der Dijs B; Acosta E; Gómez F; Lechin E; Arocha L
    J Affect Disord; 1983 Feb; 5(1):19-26. PubMed ID: 6220040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of clomipramine and lithium on fenfluramine-induced hormone release in major depression.
    Shapira B; Yagmur MJ; Gropp C; Newman M; Lerer B
    Biol Psychiatry; 1992 May; 31(10):975-83. PubMed ID: 1511080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fengabine, a new GABAmimetic agent in the treatment of depressive disorders: an overview of six double-blind studies versus tricyclics.
    Magni G; Garreau M; Orofiamma B; Palminteri R
    Neuropsychobiology; 1989; 20(3):126-31. PubMed ID: 2668780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clomipramine and imipramine in obsessive-compulsive disorder.
    Volavka J; Neziroglu F; Yaryura-Tobias JA
    Psychiatry Res; 1985 Jan; 14(1):85-93. PubMed ID: 3887445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tricyclic antidepressants in obsessive-compulsive disorder: antiobsessional or antidepressant agents? II.
    Mavissakalian M; Turner SM; Michelson L; Jacob R
    Am J Psychiatry; 1985 May; 142(5):572-6. PubMed ID: 3885761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An outpatient evaluation of phenelzine and imipramine.
    Davidson J; Raft D; Pelton S
    J Clin Psychiatry; 1987 Apr; 48(4):143-6. PubMed ID: 3549705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of joint administration of imipramine and amantadine in patients with drug-resistant unipolar depression.
    Rogóz Z; Dziedzicka-Wasylewska M; Daniel WA; Wójcikowski J; Dudek D; Wróbel A; Zieba A
    Pol J Pharmacol; 2004; 56(6):735-42. PubMed ID: 15662086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulse intravenous clomipramine for depressed adolescents: double-blind, controlled trial.
    Sallee FR; Vrindavanam NS; Deas-Nesmith D; Carson SW; Sethuraman G
    Am J Psychiatry; 1997 May; 154(5):668-73. PubMed ID: 9137123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Superiority of clomipramine over imipramine in the treatment of panic disorder: a placebo-controlled trial.
    Modigh K; Westberg P; Eriksson E
    J Clin Psychopharmacol; 1992 Aug; 12(4):251-61. PubMed ID: 1527228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of symptom change from improvement curves on the Hamilton depression scale in trials with antidepressants.
    Bech P; Allerup P; Reisby N; Gram LF
    Psychopharmacology (Berl); 1984; 84(2):276-81. PubMed ID: 6438690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term efficacy and safety of milnacipran compared to clomipramine in patients with major depression.
    Leinonen E; Lepola U; Koponen H; Mehtonen OP; Rimon R
    Acta Psychiatr Scand; 1997 Dec; 96(6):497-504. PubMed ID: 9421348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of clomipramine and doxepin in neurotic depression.
    Kornhaber A; Horwitz IM
    J Clin Psychiatry; 1984 Aug; 45(8):337-41. PubMed ID: 6378895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial increase of plasma serotonin: a biological predictor for the antidepressant response to clomipramine?
    Spreux-Varoquaux O; Gailledreau J; Vanier B; Bothua D; Plas J; Chevalier JF; Advenier C; Pays M; Brion S
    Biol Psychiatry; 1996 Sep; 40(6):465-73. PubMed ID: 8879466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compared efficacy of prazepam and clomipramine in major depression with anxiety: a multicenter controlled study.
    Lemoine P; Boulenger JP; Caillard V; Tanne N; Bonnet D
    Pharmacopsychiatry; 1991 Sep; 24(5):175-9. PubMed ID: 1775523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of imipramine on depression and obsessive-compulsive symptoms.
    Foa EB; Steketee G; Kozak MJ; Dugger D
    Psychiatry Res; 1987 Jun; 21(2):123-36. PubMed ID: 3615688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relevance of tryptophan and tyrosine availability in endogenous and 'non-endogenous' depressives treated with imipramine or clomipramine.
    Møller SE; Reisby N; Ortmann J; Elley J; Krautwald O
    J Affect Disord; 1981 Sep; 3(3):231-44. PubMed ID: 6456290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, double-blind, parallel-group comparison of venlafaxine and clomipramine in outpatients with major depression.
    Samuelian JC; Hackett D
    J Psychopharmacol; 1998; 12(3):273-8. PubMed ID: 10958254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolactin response to fenfluramine and placebo challenge following maintenance pharmacotherapy withdrawal in remitted depressed patients.
    Shapira B; Cohen J; Newman ME; Lerer B
    Biol Psychiatry; 1993 Apr; 33(7):531-5. PubMed ID: 8513038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient predictors of response to psychotherapy and pharmacotherapy: findings in the NIMH Treatment of Depression Collaborative Research Program.
    Sotsky SM; Glass DR; Shea MT; Pilkonis PA; Collins JF; Elkin I; Watkins JT; Imber SD; Leber WR; Moyer J
    Am J Psychiatry; 1991 Aug; 148(8):997-1008. PubMed ID: 1853989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.